<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03027492</url>
  </required_header>
  <id_info>
    <org_study_id>ACPM15</org_study_id>
    <nct_id>NCT03027492</nct_id>
  </id_info>
  <brief_title>Gynaecological Disorders in Not-celiac Wheat Sensitivity</brief_title>
  <official_title>Gynaecological Disorders in Patients With Not-celiac Wheat Sensitivity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Palermo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Palermo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the last few years, a new clinical entity has emerged which includes patients who consider
      themselves to be suffering from problems caused by wheat and/or gluten ingestion, even though
      they do not have celiac disease (CD) or wheat allergy. This clinical condition has been named
      non-celiac gluten sensitivity (NCGS), although in a recent article, the investigators
      suggested the term &quot;non-celiac wheat sensitivity&quot; (NCWS), because it is not known to date
      what component of wheat actually causes the symptoms. The clinical picture of NCWS is
      characterized by combined gastrointestinal (bloating, abdominal pain, diarrhea and/or
      constipation, nausea, epigastric pain, gastroesophageal reflux, aphthous stomatitis) and very
      different extra-intestinal and systemic manifestations (headache, depression, anxiety, 'foggy
      mind,' tiredness, dermatitis or skin rash, fibromyalgia-like joint/muscle pain, leg or arm
      numbness, and anemia). Nowadays, there no data about a possible relationship between
      gynaecological disorders and food ingestion and food allergy/intolerance. Therefore, the aims
      of the present study are to investigate 1) the prevalence and characteristics of
      gynaecological disorders in NCWS patients compared to CD and irritable bowel syndrome (IBS)
      controls, and 2) the modification of such disorders in NCWS patients after a gluten
      (wheat)-free diet.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the last few years, a new clinical entity has emerged which includes patients who consider
      themselves to be suffering from problems caused by wheat and/or gluten ingestion, even though
      they do not have CD or wheat allergy. This clinical condition has been named non-celiac
      gluten sensitivity (NCGS), although in a recent article, the investigators suggested the term
      &quot;non-celiac wheat sensitivity&quot; (NCWS), because it is not known to date what component of
      wheat actually causes the symptoms. Other areas of doubt in NCWS regard its pathogenesis,
      while some papers reported intestinal immunologic activation, others linked NCWS to the
      dietary short chain carbohydrate (fermentable oligo-di-monosaccharides and polyols, FODMAPs)
      load. The investigators recently demonstrated that higher proportions of patients with NCWS
      develop autoimmune disorders, are antinuclear antibodies (ANA) positive, and show DQ2/DQ8
      haplotypes compared with patients with IBS, supporting an immunologic involvement in NCWS.
      The clinical picture of NCWS is characterized by combined gastrointestinal (bloating,
      abdominal pain, diarrhea and/or constipation, nausea, epigastric pain, gastroesophageal
      reflux, aphthous stomatitis) and very different extra-intestinal and systemic manifestations
      (headache, depression, anxiety, 'foggy mind,' tiredness, dermatitis or skin rash,
      fibromyalgia-like joint/muscle pain, leg or arm numbness, and anemia). Nowadays, there no
      data about a possible relationship between gynaecological disorders (i.e. menstrual cycle
      alterations, vaginitis, recurrent vulvovaginitis, recurrent cystitis, chronic pelvic pain,
      recurrent pregnancy loss, infertility) and food ingestion and food allergy/intolerance.
      Therefore, the aims of the present study are to investigate 1) the prevalence and
      characteristics of gynaecological disorders in NCWS patients compared to CD and IBS controls,
      and 2) the modification of such disorders in NCWS patients after a gluten (wheat)-free diet.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2001</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gynaecological disorders in NCWS female patients at baseline</measure>
    <time_frame>Up to 200 months</time_frame>
    <description>Prevalence of gynaecological disorders in retrospective and prospective NCWS female patients, compared to retrospective and prospective CD and IBS female patients.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gynaecological disorders in NCWS female patients after gluten-free diet.</measure>
    <time_frame>Change from baseline at 6 months of gluten-free diet</time_frame>
    <description>Gynaecological disorders evaluation after at least 6 months of gluten-free diet after the NCWS diagnosis, by visual analogic scales, specific questionnaire, and clinical examination, both in retrospective and prospective NCWS female patients.</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Non-celiac Wheat Sensitivity</condition>
  <arm_group>
    <arm_group_label>1. NCWS retrospective patients</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The clinical charts of NCWS female patients attending the outpatient centers of the Department of Internal Medicine at the University Hospital of Palermo and the Department of Internal Medicine of the Hospital of Sciacca will be reviewed with a retrospective method. They had all been diagnosed with NCWS between January 2001 and June 2011 and included in a previously published study. These charts included specific sections for associated gynaecological disorders. Incomplete clinical charts will be excluded. All the patients will be evaluated at baseline (i.e. at diagnosis) and after at least a 6-months period of gluten-free diet.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2. CD retrospective control patients</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>To compare the presence and characteristics of gynaecological disorders in NCWS female patients, a control group of CD female patients had been randomly chosen by a computer-generated method from female patients diagnosed during the same period (2001-2011) and age- (+2 years) matched with the NCWS female patients. Similar to NCWS patients, also this control group was asked for gynaecological disorders and the answers reported in the patients clinical charts. All the patients will be evaluated at baseline (i.e. at diagnosis) and after at least a 6-months period of gluten-free diet.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3. IBS retrospective control patients</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>To compare the presence and characteristics of gynaecological disorders in NCWS female patients, a control group of IBS female patients had been randomly chosen by a computer-generated method from female subjects diagnosed during the same period (2001-2011) and age- (+2 years) matched with the NCWS female patients. Similar to NCWS patients, also this control group was asked for gynaecological disorders and the answers reported in the patients clinical charts. All the patients will be evaluated at baseline (i.e. at diagnosis) and after at least a 6-months period of gluten-free diet.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4. NCWS prospective patients</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The investigators prospectively will survey adult female patients with functional gastroenterological symptoms according to the Rome III criteria, and a suspected diagnosis of NCWS. The patients will be recruited between January 2017 and January 2018 at the same 2 centers. Most of the patients will be referred owing to gastrointestinal and extraintestinal symptoms, the onset of which, they reported, could be related to wheat ingestion. In addition, patients will be asked about the presence and characteristics of gynaecological disorders using an ad hoc questionnaire. All the patients will be evaluated at baseline (i.e. at diagnosis) and after at least a 6-months period of gluten-free diet.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5. CD prospective control patients</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>To compare the presence and characteristics of gynaecological disorders in NCWS female patients, a control group of CD female patients will be randomly chosen by a computer-generated method from female subjects diagnosed during the same period (2017-2018) and age- (+2 years) matched with the NCWS female patients. Similar to NCWS patients, also this control group will be asked for gynaecological disorders and the answers reported in the patients clinical charts. All the patients will be evaluated at baseline (i.e. at diagnosis) and after at least a 6-months period of gluten-free diet.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>6. IBS prospective control patients</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>To compare the presence and characteristics of gynaecological disorders in NCWS female patients, a control group of IBS female patients will be randomly chosen by a computer-generated method from female subjects diagnosed during the same period (2017-2018) and age- (+2 years) matched with the NCWS female patients. Similar to NCWS patients, also this control group will be asked for gynaecological disorders and the answers reported in the patients clinical charts. All the patients will be evaluated at baseline (i.e. at diagnosis) and after at least a 6-months period of gluten-free diet.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Gluten free diet</intervention_name>
    <description>The investigators will evaluate the modification of gynaecological disorder after a gluten (wheat)-free diet.</description>
    <arm_group_label>1. NCWS retrospective patients</arm_group_label>
    <arm_group_label>2. CD retrospective control patients</arm_group_label>
    <arm_group_label>3. IBS retrospective control patients</arm_group_label>
    <arm_group_label>4. NCWS prospective patients</arm_group_label>
    <arm_group_label>5. CD prospective control patients</arm_group_label>
    <arm_group_label>6. IBS prospective control patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        To diagnose NCWS the recently proposed criteria will be adopted. All the patients will meet
        the following criteria:

          -  negative serum anti-transglutaminase (anti-tTG) and anti-endomysium (EmA)
             immunoglobulin (Ig)A and IgG antibodies

          -  absence of intestinal villous atrophy

          -  negative IgE-mediated immune-allergy tests to wheat (skin prick tests and/or serum
             specific IgE detection)

          -  resolution of the IBS symptoms on standard elimination diet, excluding wheat, cow's
             milk, egg, tomato, chocolate, and other self-reported food(s) causing symptoms

          -  symptom reappearance on double-blind placebo-controlled (DBPC) wheat challenge. As the
             investigators previously described in other studies, DBPC cow's milk protein challenge
             and other &quot;open&quot; food challenges will be performed too.

        To diagnose CD the standard criteria will be adopted. All the patients will meet the
        following criteria:

          -  positive serum anti-transglutaminase (anti-tTG) and anti-endomysium (EmA)
             immunoglobulin (Ig)A and IgG antibodies

          -  presence of intestinal villous atrophy.

        To diagnose IBS the standard Rome II (for retrospective patients) and Rome III (for
        prospective patients) Criteria will be adopted. None of these subjects improved on an
        elimination diet without wheat, cow's milk, egg, tomato, or chocolate.

        Exclusion Criteria:

        For NCWS diagnosis it will be evaluated the following exclusion criteria:

          -  positive EmA in the culture medium of the duodenal biopsies, also in the case of
             normal villi/crypts ratio in the duodenal mucosa

          -  self-exclusion of wheat from the diet and refusal to reintroduce it before entering
             the study

          -  other previously diagnosed gastrointestinal disorders

          -  other previously diagnosed gynaecological disorders

          -  nervous system disease and/or major psychiatric disorder

          -  physical impairment limiting physical activity.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio Carroccio, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Palermo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Antonio Carroccio, PhD</last_name>
    <phone>+390916552884</phone>
    <email>acarroccio@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pasquale Mansueto, MD</last_name>
    <phone>+390916552884</phone>
    <email>pasquale.mansueto@unipa.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Internal Medicine, Giovanni Paolo II Hospital of Sciacca</name>
      <address>
        <city>Sciacca</city>
        <state>Agrigento</state>
        <zip>92019</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Carroccio, MD, PhD</last_name>
      <phone>+390916554347</phone>
      <email>acarroccio@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Internal Medicine, University Hospital of Palermo</name>
      <address>
        <city>Palermo</city>
        <zip>90129</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pasquale Mansueto, MD</last_name>
      <phone>+390916554347</phone>
      <email>pasquale.mansueto@unipa.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <results_reference>
    <citation>Di Liberto D, Mansueto P, D'Alcamo A, Lo Pizzo M, Lo Presti E, Geraci G, Fayer F, Guggino G, Iacono G, Dieli F, Carroccio A. Predominance of Type 1 Innate Lymphoid Cells in the Rectal Mucosa of Patients With Non-Celiac Wheat Sensitivity: Reversal After a Wheat-Free Diet. Clin Transl Gastroenterol. 2016 Jul 7;7(7):e178. doi: 10.1038/ctg.2016.35.</citation>
    <PMID>27388423</PMID>
  </results_reference>
  <results_reference>
    <citation>Mansueto P, D'Alcamo A, Seidita A, Carroccio A. Food allergy in irritable bowel syndrome: The case of non-celiac wheat sensitivity. World J Gastroenterol. 2015 Jun 21;21(23):7089-109. doi: 10.3748/wjg.v21.i23.7089. Review.</citation>
    <PMID>26109796</PMID>
  </results_reference>
  <results_reference>
    <citation>Carroccio A, Soresi M, D'Alcamo A, Scium√® C, Iacono G, Geraci G, Brusca I, Seidita A, Adragna F, Carta M, Mansueto P. Risk of low bone mineral density and low body mass index in patients with non-celiac wheat-sensitivity: a prospective observation study. BMC Med. 2014 Nov 28;12:230. doi: 10.1186/s12916-014-0230-2.</citation>
    <PMID>25430806</PMID>
  </results_reference>
  <results_reference>
    <citation>Mansueto P, Seidita A, D'Alcamo A, Carroccio A. Non-celiac gluten sensitivity: literature review. J Am Coll Nutr. 2014;33(1):39-54. doi: 10.1080/07315724.2014.869996. Review.</citation>
    <PMID>24533607</PMID>
  </results_reference>
  <results_reference>
    <citation>Carroccio A, Rini G, Mansueto P. Non-celiac wheat sensitivity is a more appropriate label than non-celiac gluten sensitivity. Gastroenterology. 2014 Jan;146(1):320-1. doi: 10.1053/j.gastro.2013.08.061. Epub 2013 Nov 22.</citation>
    <PMID>24275240</PMID>
  </results_reference>
  <results_reference>
    <citation>Carroccio A, Mansueto P, D'Alcamo A, Iacono G. Non-celiac wheat sensitivity as an allergic condition: personal experience and narrative review. Am J Gastroenterol. 2013 Dec;108(12):1845-52; quiz 1853. doi: 10.1038/ajg.2013.353. Epub 2013 Nov 5. Review.</citation>
    <PMID>24169272</PMID>
  </results_reference>
  <results_reference>
    <citation>Carroccio A, Mansueto P, Iacono G, Soresi M, D'Alcamo A, Cavataio F, Brusca I, Florena AM, Ambrosiano G, Seidita A, Pirrone G, Rini GB. Non-celiac wheat sensitivity diagnosed by double-blind placebo-controlled challenge: exploring a new clinical entity. Am J Gastroenterol. 2012 Dec;107(12):1898-906; quiz 1907. doi: 10.1038/ajg.2012.236. Epub 2012 Jul 24.</citation>
    <PMID>22825366</PMID>
  </results_reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 30, 2016</study_first_submitted>
  <study_first_submitted_qc>January 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 23, 2017</study_first_posted>
  <last_update_submitted>February 14, 2018</last_update_submitted>
  <last_update_submitted_qc>February 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Palermo</investigator_affiliation>
    <investigator_full_name>Pasquale Mansueto</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Non-celiac Wheat Sensitivity</keyword>
  <keyword>gynaecological disorders</keyword>
  <keyword>gluten-free diet</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

